Revvity Inc vs Uber Technologies Inc — how do they compare? Revvity Inc trades at $154.18 (market cap $16.98B), while Uber Technologies Inc trades at $71.51 (market cap $143.47B). The key difference: Uber Technologies Inc is far larger — about 8.4× Revvity Inc's market cap, and Revvity Inc pays a 0.18% dividend while Uber Technologies Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Revvity Inc for 12 Days and Uber Technologies Inc for 88 Days on average.
| RVTY | UBER | |
|---|---|---|
Market Cap | $16.98B | $143.47B |
Volume | 1,456,900 | 14,430,657 |
Sector | Health | Technology |
52-Week High | $157.36 | $99.72 |
52-Week Low | $82.26 | $65.94 |
Typical Hold Time | 12 Days | 88 Days |
Enterprise Value | $19.30B | $152.81B |
Dividend Yield | 0.18% | — |
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.
The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.
Uber (UBER) trades at $70.24, up 2.62% on the day, with a bullish technical signal and strong fundamental momentum. Revenue grew to $52.02B in 2025, with net income of $10.05B and improving cash flow from operations. Recent news highlights expansion of the Uber Eats partnership with Costco to 47 states, enhancing delivery reach. The stock shows resilience with earnings beats in recent quarters and robust analyst support.
The outlook for Uber remains positive, driven by revenue growth, strategic expansions, and strong cash generation. Key risks include competitive pressures in mobility and delivery, execution of autonomous vehicle initiatives, and macroeconomic sensitivity. With 82.5% analyst buy ratings and a consensus price target of $104.72, the stock presents upside potential, though investors should monitor profit margin trends and competitive dynamics.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.
Read more on UBER →